Gemini Pharmaceuticals, Inc. dba Plus Pharma [New York / United States of America]

Gemini Pharmaceuticals, Inc. dba Plus Pharma [New York / United States of America] located in NEW YORK NY, United States of America had its last known inspection on 26 Jul 2022. There are 16 known inspections on record.

Site Details

Industries:
Human Drugs, Animal Health, Food, Food and Cosmetics
Tags:
OTC Manufacturer, Animal Health, Human Drugs, FDF Manufacturer, Animal Health: Animal Drugs, Manufacturer, Food: Manufacturer, Labels, Food and Cosmetics, Food
Last Inspection Date:
26 Jul 2022
FEI:
2432926
Redica ID:

Gemini Pharmaceuticals, Inc. dba Plus Pharma [New York / United States of America]'s Most Recent Documents

Publish Date Document Type Title
July, 2022 FDA 483 Gemini Pharmaceuticals, Inc. dba Plus Pharma - Form 483, 2022-07-26
February, 2018 EIR Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2018-02-16
February, 2018 FDA 483 Gemini Pharmaceuticals, Inc. dba Plus Pharma - Form 483, 2018-02-16
June, 2015 FDA 483 Gemini Pharmaceuticals, Inc. dba Plus Pharma - Form 483, 2015-06-30
June, 2015 EIR Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2015-06-30

Experience Redica Systems’s NEW site dashboards and profiles

Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Loading...

Site Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more